Image may be NSFW.
Clik here to view.
Clik here to view.
Enlivex gets EMA orphan drug status for ApoCell
Enlivex Therapeutics, a member of the Hadasit Bio-Holdings group (TASE:HDST; OTCQB:HDASY), has received orphan drug status from the European Medicines Agency (EMA) for its lead product candidate,...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
KAHR Medical on financing trail to develop dual signaling proteins
Closely-held KAHR Medical of Israel is seeking to raise* as much as $10-million in the U.S. and Europe to continue development of its dual signaling proteins (DSPs), including KAHR-102, its lead drug...
View Article
More Pages to Explore .....
